X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (82) 82
index medicus (52) 52
male (39) 39
female (38) 38
life sciences (33) 33
hematology (32) 32
aged (31) 31
middle aged (28) 28
adult (24) 24
peripheral vascular disease (24) 24
venous thromboembolism (23) 23
prevention (21) 21
anticoagulants (20) 20
pulmonary embolism (20) 20
risk factors (20) 20
thromboembolism (19) 19
aged, 80 and over (17) 17
deep-vein thrombosis (16) 16
anticoagulants - administration & dosage (15) 15
mesh : humans (15) 15
thrombosis (15) 15
anticoagulants - therapeutic use (14) 14
human health and pathology (14) 14
meta-analysis (14) 14
pharmacology (14) 14
pharmacology & pharmacy (14) 14
prospective studies (14) 14
treatment outcome (14) 14
medicine, general & internal (13) 13
recurrence (13) 13
risk (13) 13
venous thrombosis (13) 13
mesh : female (12) 12
pharmaceutical sciences (12) 12
warfarin (12) 12
abridged index medicus (11) 11
drug therapy (11) 11
pharmacokinetics (11) 11
venous thromboembolism - prevention & control (11) 11
[ sdv.sp.pharma ] life sciences [q-bio]/pharmaceutical sciences/pharmacology (10) 10
cohort studies (10) 10
enoxaparin (10) 10
guidelines (10) 10
hemorrhage - chemically induced (10) 10
mesh : male (10) 10
anticoagulants - adverse effects (9) 9
clinical trials (9) 9
double-blind method (9) 9
hematology, oncology and palliative medicine (9) 9
metaanalysis (9) 9
molecular-weight heparin (9) 9
randomized controlled trials as topic (9) 9
surgery (9) 9
therapy (9) 9
administration, oral (8) 8
analysis (8) 8
mesh : middle aged (8) 8
models, biological (8) 8
prognosis (8) 8
prophylaxis (8) 8
risk assessment (8) 8
cancer (7) 7
dabigatran (7) 7
fondaparinux (7) 7
heparin (7) 7
mesh : adult (7) 7
mesh : aged (7) 7
mesh : anticoagulants (7) 7
mesh : pulmonary embolism (7) 7
predictive value of tests (7) 7
pregnancy (7) 7
pulmonary-embolism (7) 7
venous thrombosis - drug therapy (7) 7
[ sdv.mhep ] life sciences [q-bio]/human health and pathology (6) 6
acute disease (6) 6
anticoagulants - pharmacokinetics (6) 6
blood coagulation, fibrinolysis and cellular haemostasis (6) 6
care and treatment (6) 6
deep vein thrombosis (6) 6
deep venous thrombosis (6) 6
diagnosis (6) 6
dosage and administration (6) 6
double-blind (6) 6
internal medicine (6) 6
mesh : venous thrombosis (6) 6
mortality (6) 6
research (6) 6
respiratory system (6) 6
risk-factors (6) 6
rivaroxaban (6) 6
stroke (6) 6
venous thrombosis - complications (6) 6
venous thrombosis - prevention & control (6) 6
young adult (6) 6
[ sdv ] life sciences [q-bio] (5) 5
[sdv.mhep]life sciences [q-bio]/human health and pathology (5) 5
comorbidity (5) 5
enoxaparin - therapeutic use (5) 5
follow-up studies (5) 5
france (5) 5
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet, The, ISSN 0140-6736, 2011, Volume 378, Issue 9796, pp. 1079 - 1088
Summary Background Platinum-based doublet chemotherapy is recommended to treat advanced non-small-cell lung cancer (NSCLC) in fit, non-elderly adults, but... 
Internal Medicine | SURVIVAL | MEDICINE, GENERAL & INTERNAL | MANAGEMENT | INTERNATIONAL-SOCIETY | GERIATRIC ASSESSMENT | UNDERREPRESENTATION | OLDER | OUTCOMES | COMBINATION | AGE | COMORBIDITY | Lung Neoplasms - drug therapy | Lung Neoplasms - mortality | Humans | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Antineoplastic Agents - therapeutic use | Vinblastine - administration & dosage | Carboplatin - adverse effects | Carcinoma, Squamous Cell - mortality | Vinblastine - analogs & derivatives | Antineoplastic Agents - adverse effects | Aged, 80 and over | Female | Paclitaxel - administration & dosage | Drug Administration Schedule | Deoxycytidine - administration & dosage | Carboplatin - administration & dosage | Paclitaxel - adverse effects | Survival Rate | Adenocarcinoma - drug therapy | Carcinoma, Non-Small-Cell Lung - mortality | Carcinoma, Squamous Cell - drug therapy | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Aged | Carcinoma, Non-Small-Cell Lung - drug therapy | Deoxycytidine - analogs & derivatives | Adenocarcinoma - mortality | Clinical trials | Chemotherapy | Radiation therapy | Cancer therapies | Adenocarcinoma | Vinblastine | Carcinoma, Non-Small-Cell Lung | Antineoplastic Agents | Antineoplastic Combined Chemotherapy Protocols | Lung Neoplasms | Carcinoma, Squamous Cell | Life Sciences | Deoxycytidine | Paclitaxel | Carboplatin | Cancer
Journal Article
JACC (Journal of the American College of Cardiology), ISSN 0735-1097, 2014, Volume 63, Issue 16, pp. 1675 - 1683
Journal Article
Alternative and Complementary Therapies, ISSN 1076-2809, 09/2017, Volume 72, Issue 4, pp. 421 - 426
Journal Article
Therapie, ISSN 0040-5957, 09/2017, Volume 72, Issue 4, pp. 421 - 426
The use of statistical test is central in the clinical trial. At the statistical level, obtaining a P < 0.05 allows to claim the effectiveness of the new... 
False positive results | Clinical trials | Type 1 error | Statistical power
Journal Article
Journal Article
Pharmacological Research, ISSN 1043-6618, 04/2017, Volume 118, pp. 1 - 1
Journal Article
Medecine Therapeutique, ISSN 1264-6520, 10/2013, Volume 19, Issue 4, pp. 346 - 347
Journal Article
JAMA, ISSN 0098-7484, 07/2015, Volume 314, Issue 1, pp. 31 - 40
Journal Article
Medecine Therapeutique, ISSN 1264-6520, 07/2012, Volume 18, Issue 3, pp. 219 - 236
Journal Article
Medecine Therapeutique, ISSN 1264-6520, 07/2012, Volume 18, Issue 3, pp. 213 - 218
Journal Article
Journal Article
Journal Article
Correspondances en MHND, ISSN 2100-9619, 01/2015, Volume 19, Issue 1-2, pp. 32 - 35
Journal Article
PLoS ONE, ISSN 1932-6203, 03/2017, Volume 12, Issue 3, p. e0173596
Journal Article
19.